Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-1985 | |
| Assets | |
| Current Assets | |
| Other current assets | 159 |
| TOTAL | $159 |
| Non-Current Assets | |
| PPE Net | 3,114 |
| Other Non-Current Assets | 6,975 |
| TOTAL | $10,089 |
| Total Assets | $10,249 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 3,000 |
| Accounts payable and accrued liabilities | 3,670 |
| Accrued Expenses | 1,200 |
| TOTAL | $7,870 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 273 |
| TOTAL | $464 |
| Total Liabilities | $8,334 |
| Shareholders' Equity | |
| Common Shares | 19 |
| TOTAL | $7,119 |
| Total Liabilities And Equity | $15,453 |